The deleterious effects of long-term cyclosporine a, cyclosporine g, and fk506 on bone mineral metabolism in vivo

Transplantation

Volumn 57, Issue 8, 1994, Pages 1231-1237

  Cvetkovic, Mirjana ^a   Mann, Gary N ^a   Romero, David F ^a   Liang, Xlao G ^b   Ma, Yanfei ^b   Jee, Webster S S ^b   Epstein, Sol ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCEIN; CALCITRIOL; CYCLOSPORIN A; CYCLOSPORIN G; OSTEOCALCIN; PARATHYROID HORMONE; TACROLIMUS;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE REMODELING; CONTROLLED STUDY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MORPHOMETRICS; NONHUMAN; ORAL DRUG ADMINISTRATION; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; TIBIA; VITAMIN BLOOD LEVEL;

ANIMAL; BODY WEIGHT; BONE RESORPTION; CALCIFICATION, PHYSIOLOGIC; CALCITRIOL; CYCLOSPORINE; CYCLOSPORINS; FEMALE; IMMUNOSUPPRESSIVE AGENTS; MALE; OSTEOCALCIN; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY; TACROLIMUS; TIBIA; TIME FACTORS;

EID: 0028348583     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199404270-00016     Document Type: Article

References (47)

1. Bougneres PF, Carel JC, Castano L, et al. Factors associated with early remission of Type 1 diabetes in children treated with cyclosporine. N Engl J Med 1988; 318: 663.
2. Mochizuki M, Ikeda E, Shirao M, Fujito S, Yoshimura K, Shimada N. Preclinical and clinical study of FK506 in uveitis. Curr Eye Res 1992; 11: 87.
3. Tugwell P, Bombardier C, Gent M, et al. Low-dose cyclosporine versus placebo in patients with rheumatoid arthritis. Lancet 1990; 335: 1051.
4. Tejani A, Butt K, Khawar R, et al. Cyclosporine induced remis sion of relapsing nephrotic syndrome in children. Kidney Int 1986; 29: 206.
5. Ellis CN, Gorsulowsky DC, Hamilton TA, et al. Cyclosporine improves psoriasis in a double-blind study. JAMA 1986; 256: 3110.
6. Kahan BD. Cyclosporine. N Engl J Med 1989; 321: 1725.
7. Keown PA, Stiller CR. Cyclosporine: a double-edged sword. Hosp Pract 1987; 22: 207.
8. Movsowitz C, Epstein S, Ismail F, Fallon M, Thomas S. Cyclo sporine A in the oophorectomized rat: unexpected severe bone resorption. J Bone Mineral Res 1989; 4: 393.
9. Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S. Cyclo sporine A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology 1988; 123: 2571.
10. Traber R, Loosli HR, Hoffman H, Von Wartberg A. Isolierung und strukturemittlung der neuen cyclosporin E, F, G, H und I. Helv Chir Acta 1982; 65: 1342.
11. Faraci M, Vigeant C, Yale JF. Pharmacokinetic profile of cyclo sporine A and G and their effects on cellular immunity and glucose tolerance in male and female wistar rats. Transplantation 1988; 45: 617.
12. McKenna RM, Szturm K, Jeffery JR, Rush DN. Inhibition of cytokine production by cyclosporine A and G. Transplantation 1989; 47: 343.
13. Caine RY, White DJG, Thiru S, Rolles K, Drakopoulos S, Jamieson NV. Cyclosporine G: immunosuppressive effects in dogs with renal allografts. Lancet 1985; 2: 1342.
14. Rooth P, Dawidson I, Diller K, Clothier N. In vivo fluorescence microscopy reveals cyclosporine G to be less nephrotoxic than cyclosporine A. Transplant Proc 1988; 20: 707.
15. Tejani A, Lancman I, Pomarantz A, Khawar M, Chen C. Neph-rotoxity of cyclosporine A and cyclosporine G in a rat model. Transplantation 1988; 45: 184.
16. Stein B, Takizawa M, Schlosberg M, et al. Evidence that cyclo sporine G is less deleterious to rat bone in vivo than cyclosporine A. Transplantation 1992; 53: 628.
17. Kino T, Hatanaka H, Hashimoto M. FK506, a novel immuno-suppressant isolated from a Streptomyces: I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot 1987; 40: 1249.
18. Schreiber SL. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 1991; 251: 283.
19. McKeon F. When worlds collide: immunosuppressants meet pro tein phosphatases. Cell 1991; 66: 823.
20. Siekierka JJ, Sigal NH. FK506 and cyclosporine A: immunosup pressive mechanism of action and beyond. Curr Opin Immunol 1992; 4: 548.
21. Thomson AW. Interspecies comparison of the immunosuppres sive efficacy and safety of FK506. Transplant Proc 1990; 22: 100.
22. Starzl TE, Fung J, Jordan M, et al. Kidney transplantation under FK506. JAMA 1990; 264: 63.
23. Starzl TE, Fung J, Venkataramman R, Todo S, Demetris AJ, Jain A. FK506 for liver, kidney, and pancreas transplantation. Lancet 1989; 1: 1000.
24. Shapiro R, Fung JJ, Jain AB, Parks P, Todo S, Starzl TE. The side effects of FK506 in humans. Transplant Proc 1990; 22: 35.
25. Katz IA, Takizawa M, Joffe IL, Stein B, Fallon MD, Epstein S. Comparison of the effects of FK506 and cyclosporine on bone mineral metabolism in the rat: a pilot study. Transplantation 1991; 52: 571.
26. Jowell PS, Epstein S, Fallon MD, Reinhardt TA, Ismail F. 1,25-dihydroxyvitamin D3 modulates glucocorticoid-induced alteration in serum bone gla protein and bone histomorphometry. Endocrinology 1987; 120: 531.
27. Toverud SV, Boass A, Gamer SC, Endress DB. Circulating para thyroid hormone concentrations in normal and vitamin D-deprived rat pups determined with N-terminal-specific radioimmunoassay. Bone 1986; 1: 145.
28. Jee WSS, Inoue J, Jee KW, Haba T. Histomorphometric assay of the growing long bone. In: Takahashi H, ed. Handbook of bone morphology. Niigata City: Nishimura, 1983: 101.
29. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomor phometry: standardization of nomenclature, symbols and units: report of the ASBMR Histomorphometry Committee. J Bone Mineral Res 1987; 2: 595.
30. Wenk M, Bindschedler M, Costa E. Pharmokinetics of cyclospo rine G in patients with renal failure. Transplantation 1988; 45: 558.
31. Stein B, Halloran BP, Reinhardt G, et al. Cyclosporine A in creases synthesis of 1,25 dihydroxyvitamin D3 in the rat and mouse. Endocrinology 1991; 128: 1369.
32. Jacobs TW, Epstein S. Current status of serum-derived bone proteins. In: Davidovitch Z, ed. The biological mechanisms of tooth movement and craniofacial adaptation. Columbus: Ohio State University College of Dentistry, 1992: 149.
33. Lian J, Stewart C, Puchacz E. Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci USA 1989; 86: 1143.
34. Delmas PD, Malaval L, Arlot MD, et al. Serum bone gla-protein is not a sensitive marker of bone turnover in Paget's disease of bone. Calcif Tissue Int 1986; 38: 329.
35. Gowen M. Interleukin 1 and tumor necrosis factor. In: Gowen M, ed. Cytokines and bone metabolism. Boca Raton, FL: CRC, 1992: 71.
36. Horowitz MC. Cytokines and estrogen in bone: anti-osteoporotic effects. Science 1993; 260: 626.
37. Katz IA, Jee WSS, Joffe II, et al. Prostaglandin E2 alleviates cyclosporine A-induced bone loss in the rat. J Bone Mineral Res 1992; 7: 1191.
38. Stewart PJ, Green OC, Stern PH. Cyclosporine A inhibits calce-mic hormone-induced bone resorption in vitro. J Bone Mineral Res 1986; 1: 285.
39. Stewart PJ, Stem PH. Cyclosporines: correlation of immunosup pressive activity and inhibition of bone resorption. Calcif Tissue Int 1989; 45: 222.
40. Walsh CT, Zydowsky LD, McKeon FD. Cyclosporine A, the cyclophilin class of peptidylprolyl isomerases, and blockade of T-cell signal transduction. J Biol Chem 1992; 267: 13, 115.
41. McCauley LK, Rosol TJ, Charles CC. Effects of cyclosporine A on rat osteoblasts (ROS 17/2.8 cells) in vitro. Calcif Tissue Int 1992; 51: 291.
42. Katz IA, Epstein S. Posttransplantation bone disease. J Bone Mineral Res 1992; 7: 123.
43. Loertscher R, Thiel G, Harder F, Brunner FP. Persistent eleva tion of alkaline phosphatase in cyclosporine-treated renal transplant recipients. Transplantation 1982; 36: 115.
44. Bourbigot B, Moal MC, Cledes J. Bone histology in renal trans plant patients receiving cyclosporine. Lancet 1988; 1: 1048.
45. Aubia J, Masramon J, Serrano S, Lloveras J, Marinoso LL. Bone histology in renal transplant patients receiving cyclosporine. Lancet 1988; 1: 1048.
46. Rich GM, Mudge GH, Lafifel GL, Le Boff MS. Cyclosporine A and prednisone-associated osteoporosis in heart transplant recipients. J Heart Lung Transplant 1992; 11: 950.
47. Shane E, Rivas MDC, Silverberg SJ, Kim TS, Staron RB, Bilezikian JP. Osteoporosis after cardiac transplantation. Am J Med 1993; 94: 257.